Analytical and Microbial Testing
Experts Committed to Product Homogeneity and Patient Safety
From assessment of microbial contamination, quality control testing, and shelf-life, our central focus on biological analytical services and product quality will guide your molecule’s success in commercial manufacturing at every step.
Patient Safety is Our Top Priority
Our vision of a healthier world and dedication to our partner’s success inspires robust manufacturing methods supported by strong analytical development and services. Rigorous analytical and microbial testing of raw materials and manufactured products is crucial for a safe release. We have a highly skilled and knowledgeable Quality Control department on staff to guarantee compliance with all certificate of analysis requirements for both raw materials and finished goods.
The Right Test at the Right Time
As your responsive CDMO partner, we focus on providing your team with the experienced advice and insightful data needed to make critical decisions and streamline efforts. As a result, a key aspect of our rigorous testing approach is timing. Quality testing that is phase-appropriate can reduce manufacturing costs and release timeframes while maintaining regulatory compliance.
Cutting-Edge Methodologies
Analytical methods identified as suitable for product critical quality attribute analysis during development are integral to assessing the overall quality of the molecule throughout manufacturing. At Cytovance, we offer an exciting combination of analytical expertise and state-of-the-art instrumentation to provide services designed to meet your program requirements and timelines. Our labs utilize cutting-edge methodologies for product characterization and sterility, including mass spectrometry (LC-MS), HPLC, protein content, process residuals, biological potency assays, detection of bacterial endotoxins, product sterility, and other compendial methods.
Related Areas of Expertise
Contact Us
Meet Team Cytovance in 2026!
-
– BIO Investment and Growth Summit: March 2-3, Miami Beach, FL
-
– OPCU Large Molecule: March 24, Virtual
-
– World Vaccine Congress: March 30-April 2, Washington D.C. | Booth 536
– PEGS: May 11-15, Boston, MA -
– TIDES USA Oligonucleotide & Peptide Therapeutics: May 11-14, Boston, MA
-
– BIO International Convention: June 22-25, San Diego, CA | Booth 4445
-
– BioProcess International East: September 22-25, Boston, MA
-
– CPHI Europe: October 6-8, Milan, Italy
-
– CDMO Live Americas: October 19-21, Boston, MA
- – OPCU Large Molecule: October 27, Virtual